Chronic myeloid leukemia, BCR ‐ ABL 1‐positive with CALR and MPL mutations
2018; Wiley; Volume: 40; Issue: 3 Linguagem: Inglês
10.1111/ijlh.12792
ISSN1751-553X
AutoresMatthew M. Klairmont, Jinjun Cheng, Lee S. Schwartzberg, Hao Ho, Joel F. Gradowski,
Tópico(s)Eosinophilic Disorders and Syndromes
ResumoInternational Journal of Laboratory HematologyVolume 40, Issue 3 p. e41-e42 LETTER TO THE EDITOR Chronic myeloid leukemia, BCR-ABL1-positive with CALR and MPL mutations M. M. Klairmont, Corresponding Author M. M. Klairmont mklairmo@uthsc.edu orcid.org/0000-0002-4463-0835 Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USA Correspondence Matthew Klairmont, MD, Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USA. Email: mklairmo@uthsc.eduSearch for more papers by this authorJ. Cheng, J. Cheng Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USASearch for more papers by this authorL. Schwartzberg, L. Schwartzberg Department of Medicine, Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis, TN, USASearch for more papers by this authorH. H. Ho, H. H. Ho PathGroup, Nashville, TN, USASearch for more papers by this authorJ. F. Gradowski, J. F. Gradowski Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USASearch for more papers by this author M. M. Klairmont, Corresponding Author M. M. Klairmont mklairmo@uthsc.edu orcid.org/0000-0002-4463-0835 Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USA Correspondence Matthew Klairmont, MD, Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USA. Email: mklairmo@uthsc.eduSearch for more papers by this authorJ. Cheng, J. Cheng Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USASearch for more papers by this authorL. Schwartzberg, L. Schwartzberg Department of Medicine, Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis, TN, USASearch for more papers by this authorH. H. Ho, H. H. Ho PathGroup, Nashville, TN, USASearch for more papers by this authorJ. F. Gradowski, J. F. Gradowski Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USASearch for more papers by this author First published: 06 March 2018 https://doi.org/10.1111/ijlh.12792Citations: 5Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume40, Issue3June 2018Pages e41-e42 RelatedInformation
Referência(s)